Hot Products

Basic Information

Post buying leads

Suppliers

Name	Fluphenazine decanoate	EINECS	225-672-4
CAS No.	5002-47-1	Density	1.149 g/cm³
PSA	61.32000	LogP	7.94050
Solubility	N/A	Melting Point	30-32°
Formula	C₃₂H₄₄F₃N₃O₂S	Boiling Point	658.1 °C at 760 mmHg
Molecular Weight	591.781	Flash Point	351.8 °C
Transport Information	UN 3249	Appearance	N/A
Safety		Risk Codes	N/A
Molecular Structure		Hazard Symbols	N/A
Synonyms	Decanoicacid, 2-[4-[3-[2-(trifluoromethyl)phenothiazin-10-yl]propyl]-1-piperazinyl]ethylester (7CI,8CI);1-Piperazineethanol,4-[3-[2-(trifluoromethyl)phenothiazin-10-yl]propyl]-, decanoate (ester) (8CI);Dapotum D;Depot;Fluorophenazine decanoate;Lyogen;Modecate;Moditen depot;NSC 169510;Prolixindecanoate;QD 10733;SQ 10733;

Fluphenazine decanoate Chemical Properties

IUPAC Name: Fluphenazine decanoate
The MF of Fluphenazine decanoate (5002-47-1) is C₃₂H₄₄F₃N₃O₂S.

The MW of Fluphenazine decanoate (5002-47-1) is 591.77.
Synonyms of Fluphenazine decanoate (5002-47-1): 2-(4-{3-[2-(Trifluormethyl)-10H-phenothiazin-10-yl]propyl}piperazin-1-yl)ethyldecanoat ; 2-(4-{3-[2-(Trifluoromethyl)-10H-phenothiazin-10-yl]propyl}-1-piperazinyl)ethyl decanoate ; Decanoic acid 2-(4-(3-(2-(trifluoromethyl)phenothiazin-10-yl)propyl)-1-piperazinyl)ethylester
Product Categories: Organics
Index of Refraction: 1.537
EINECS: 225-672-4
Density: 1.149 g/ml
Flash Point: 351.8 °C
Boiling Point: 658.1 °C

Fluphenazine decanoate Uses

Fluphenazine decanoate (5002-47-1) is used in organic synthesis, drug manufacturing.

Fluphenazine decanoate Toxicity Data With Reference

Organism	Test Type	Route	Reported Dose (Normalized Dose)	Effect	Source
dog	LD50	intramuscular	> 1500mg/kg (1500mg/kg)		Gekkan Yakuji. Pharmaceuticals Monthly. Vol. 35, Pg. 799, 1993.
human	TDLo	intramuscular	179ug/kg (0.179mg/kg)	BEHAVIORAL: ANTIPSYCHOTIC	American Journal of Psychiatry. Vol. 121, Pg. 784, 1965.
man	TDLo	intramuscular	1071ug/kg/12D (1.071mg/kg)	BEHAVIORAL: ATAXIA SKIN AND APPENDAGES (SKIN): SWEATING: OTHER LUNGS, THORAX, OR RESPIRATION: DYSPNEA	Annals of Emergency Medicine. Vol. 16, Pg. 705, 1987.
man	TDLo	intramuscular	46mg/kg/5Y-I (46mg/kg)	BEHAVIORAL: MUSCLE CONTRACTION OR SPASTICITY)	British Journal of Psychiatry. Vol. 149, Pg. 524, 1986.
mouse	LD50	intramuscular	60mg/kg (60mg/kg)	SENSE ORGANS AND SPECIAL SENSES: OTHER: EYE BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX) SKIN AND APPENDAGES (SKIN): HAIR: OTHER	Jitchuken Zenrinsho Kenkyuho. Central Institute for Experimental Animals, Research Reports. Vol. 16, Pg. 87, 1990.
rat	LD50	intramuscular	576mg/kg (576mg/kg)	SENSE ORGANS AND SPECIAL SENSES: OTHER: EYE BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX) SKIN AND APPENDAGES (SKIN): HAIR: OTHER	Jitchuken Zenrinsho Kenkyuho. Central Institute for Experimental Animals, Research Reports. Vol. 16, Pg. 75, 1990.
rat	LD50	oral	19mg/kg (19mg/kg)	SENSE ORGANS AND SPECIAL SENSES: OTHER: EYE LUNGS, THORAX, OR RESPIRATION: RESPIRATORY DEPRESSION	Jitchuken Zenrinsho Kenkyuho. Central Institute for Experimental Animals, Research Reports. Vol. 16, Pg. 75, 1990.
women	TDLo	intramuscular	21mg/kg/6D-I (21mg/kg)	CARDIAC: PULSE RATE GASTROINTESTINAL: CHANGES IN STRUCTURE OR FUNCTION OF SALIVARY GLANDS	British Medical Journal. Vol. 286, Pg. 1016, 1983.

Fluphenazine decanoate Safety Profile

Safety information of Fluphenazine decanoate (5002-47-1):
RIDADR 3249
HazardClass 6.1(a)
PackingGroup II

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 5002-47-1